About Me

At University College London (UCL), my PhD research addresses complex challenges in drug discovery and generative modelling. I have participated in the drug discovery competitions for identifying MurD Ligase and mapping binding sites for SARS-CoV-2 (nsp13 and nsp3) using 3D interaction fingerprints. Beyond my own research, I have co-supervised more than 10 MSc theses and worked as a Teaching Assistant for Bayesian Deep Learning Methods at UCL.

I am also dedicated to bringing research into practical use and have worked to connect academia with industry in meaningful ways. Most recently, as an ML Research Scientist at Matterhorn Studio, I carried out advanced Bayesian optimization projects in direct collaboration with Novo Nordisk. Before that, I was the ML Technical Lead at London North Eastern Railway (LNER), where I built an ISO27007-compliant AWS MLOps infrastructure and led a technical team to deploy production-ready AI models. My first experience in drug discovery came as an ML R&D Consultant for April19 Discovery, focusing on molecular drug design for the central nervous system with generative models and multi-task DNNs.

If we take a step back, my background is quite broad. I have more than 15 years of experience across technology, research, and finance. Earlier, I led the Data Science team at Fractal Labs, where we developed a full production pipeline using TensorFlow Extended and secured a £300k InnovateUK grant. Before moving into machine learning, I built a strong base in applied mathematical modeling through visiting research roles at Imperial College London, Columbia University, and the Oxford-Man Institute. I began my career in quantitative finance, pricing exotic financial derivatives at KBC Global Services and consulting for PwC.

When I step away from research and mathematical modelling, my interests become a bit more unconventional. I am the creator of an artistic project best described as a multi-species, multicultural alter ego. I cannot reveal my artistic identity publicly, since Banksy already has the anonymous artist space covered, but figuring out how to sell the work while managing a constant flow of new ideas is a fascinating process in itself. I also plan to combine my creative side with my deep appreciation for canine intelligence; I am currently designing art classes for dogs, which I hope to launch later this year.

Last updated 2026-02-09